Dermatitis News

In this video, Raj Chovatiya, MD, PhD, discussed research into the OX40 inhibitor amlitelimab, as well as two topical medications, from the Maui Derm 2024 meeting, examining data into their use in treating atopic dermatitis.

In this video, Raj Chovatiya, MD, PhD, discussed research into the OX40 inhibitor rocatinlimab from the Maui Derm 2024 meeting, examining data into its use in treating atopic dermatitis.

In this video, Raj Chovatiya, MD, PhD, discussed research into the Janus kinase inhibitor ruxolitinib from the Maui Derm 2024 meeting, examining data into its use in treating atopic dermatitis.

In this video, Raj Chovatiya, MD, PhD, discussed research into the interleukin-13 blocker lebrikizumab from the Maui Derm 2024 meeting, examining data into its use in treating atopic dermatitis.

Delgocitinib cream demonstrated superiority to alitretinoin capsules in the treatment of severe chronic hand eczema, LEO Pharma announced in a press release.

Children and adolescents with difficult-to-control atopic dermatitis can benefit from a multidisciplinary approach that combines the perspectives of dermatologists, allergists and family members, according to a study.

Dermavant Sciences has submitted a supplemental new drug application to the FDA for its Vtama cream 1% for the topical treatment of atopic dermatitis in patients aged 2 years and older, according to a company press release.

Vegetarian diets during pregnancy were associated with reduced risks for atopic dermatitis among children, according to a study published in Pediatric Allergy and Immunology.

The FDA and the European Medicines Agency have accepted applications for nemolizumab for the treatment of prurigo nodularis and severe atopic dermatitis in adolescents and adults, Galderma announced in a press release.

MIAMI BEACH, Fla. — Patients with atopic dermatitis resistant to systemic therapy, including dupilumab, may benefit from tralokinumab treatment, according to a poster presentation here.